AlphaCentric Advisors’s Tourmaline Bio TRML Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,500	Closed	-$141K	–	279
2024 Q3	$141K	Sell	5,500 -69,500	-93%	-$1.79M	0.11%	151
2024 Q2	$965K	Buy	75,000 +13,900	+23%	+$179K	0.71%	48
2024 Q1	$1.4M	Buy	+61,100	New	+$1.4M	0.84%	45